ALKERMES, INC.

Awareness of the need for access to all FDA-approved medications for treatment of substance use disorder; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; H.R.4531/S.3393 Support for Patients and Communities Reauthorization Act; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings

Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Proposed Rule (CMS-2434-P) -- and operational and patient access challenges with stacking policy